PapersPMID:40647178
Benefits of Short-Term (4-Week) Daily Walnut Consumption in Middle-Aged Adults at Risk for Metabolic Syndrome: Outcomes of a Randomized Controlled Trial.
- findings
- 2
- compound
- 1
- endpoints
- 2
- Study, every finding
- crossover · 4 weeks
- Dose studied, every finding
- 45 g of walnut kernels per day
- Population, every finding
- Middle-aged adults (40-65 years) with at least one altered metabolic syndrome parameter and no medication; 28-day walnut period against a 28-day nut-free normocaloric control period, weight-maintenance diet advice in both
No finding here moved its endpoint.
What did not
How to read these marks →“Also, HDL-c did not show significant differences between the walnut and control groups, same as HbA1c changes.”
Study record
- Design
- crossover trial
- Species
- human
- Population
- Middle-aged adults (Cluj-Napoca, Romania) with at least one altered metabolic syndrome parameter and no medication; whole walnut kernels (Juglans regia) 45 g/day vs a diet without walnuts
- Participants
- 20
- Comparator
- no treatment
- Duration
- 28 days
- Endpoints measured
- 13